Chenguang Biotech Group Cash Flow-to-Debt Ratio
Chenguang Biotech Group cash flow-to-debt ratio. Chenguang Biotech Group (300138) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of CN¥524.96 Million could theoretically repay 0% of its total liabilities (CN¥4.57 Billion) in one year. Check 300138 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Chenguang Biotech Group (2007–2025)
Cash flow-to-debt ratio of Chenguang Biotech Group from 2007 to 2025. Historical debt coverage capacity for Chenguang Biotech Group across 19 annual periods. Check Chenguang Biotech Group (300138) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Chenguang Biotech Group Cash Flow-to-Debt Ratio by Year (2007–2025)
Chenguang Biotech Group cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Chenguang Biotech Group. For the full cash flow conversion analysis, see cash flow conversion of Chenguang Biotech Group.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | CN¥212.91 Million | CN¥6.07 Billion | ▲ +192.4% |
| 2024 | -0.04x | CN¥-222.81 Million | CN¥5.87 Billion | ▲ +62.8% |
| 2023 | -0.10x | CN¥-510.91 Million | CN¥5.01 Billion | ▼ -151.5% |
| 2022 | 0.20x | CN¥734.81 Million | CN¥3.71 Billion | ▲ +883.2% |
| 2021 | 0.02x | CN¥63.90 Million | CN¥3.17 Billion | ▼ -90.1% |
| 2020 | 0.20x | CN¥529.41 Million | CN¥2.59 Billion | ▲ +2417.9% |
| 2019 | -0.01x | CN¥-24.35 Million | CN¥2.77 Billion | ▲ +74.7% |
| 2018 | -0.03x | CN¥-56.18 Million | CN¥1.62 Billion | ▲ +70.3% |
| 2017 | -0.12x | CN¥-145.95 Million | CN¥1.25 Billion | ▲ +64.8% |
| 2016 | -0.33x | CN¥-321.62 Million | CN¥967.46 Million | ▼ -190.0% |
| 2015 | -0.11x | CN¥-64.66 Million | CN¥564.12 Million | ▼ -121.0% |
| 2014 | 0.55x | CN¥272.96 Million | CN¥499.69 Million | ▲ +1060.6% |
| 2013 | -0.06x | CN¥-36.47 Million | CN¥641.26 Million | ▲ +82.1% |
| 2012 | -0.32x | CN¥-142.11 Million | CN¥447.73 Million | ▼ -156.8% |
| 2011 | 0.56x | CN¥82.18 Million | CN¥147.16 Million | ▲ +163.3% |
| 2010 | -0.88x | CN¥-190.51 Million | CN¥215.92 Million | ▼ -722.6% |
| 2009 | 0.14x | CN¥27.23 Million | CN¥192.17 Million | ▲ +271.1% |
| 2008 | 0.04x | CN¥9.06 Million | CN¥237.31 Million | ▲ +114.2% |
| 2007 | -0.27x | CN¥-23.02 Million | CN¥85.49 Million | — |